Track topics on Twitter Track topics that are important to you
ChondroGene is a genomics-based company focused on the discovery and development of disease-specific therapeutic and diagnostic approaches, specializing in osteoarthritis. The Company has constructed the first known human cartilage-specific microarray, the ChondroChip™, and is continuing to characterize the gene expression of novel and known genes of the human cartilage cell in both health and disease. Its shares are publicly listed on the TSX Venture Exchange under the stock symbol YDG.
800 Petrolia Road, Unit 15,
Fax: (416) 650-0055
ChondroGene is a genomics-based company focused on the discovery and development of disease-specific therapeutic and diagnostic approaches, specializing in osteoarthritis. The Company has constructed ...
ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recogniz...
We have published hundreds of ChondroGene news stories on BioPortfolio along with dozens of ChondroGene Clinical Trials and PubMed Articles about ChondroGene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChondroGene Companies in our database. You can also find out about relevant ChondroGene Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...